ClinicalTrials.gov
public full text
Public Domain
Prevention of Acute Kidney Injury Through Biomarker-guided Nephrological Intervention
This study examines the clinical relevance of early biomarkers to detect and prevent acute kidney injury. High-risk patients for developing acute kidney injury will be screened at initial presentation (emergency department and intensive care unit) for TIMP2xIGFBP7. In case of elevated readings patients will be randomized in two arms: The control group will be treated with standard care, the intervention group will receive an early nephrologic consultation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury#832277
- KDIGO Bundle to Prevent AKI in Sepsis#1182628
- Diagnostic and prognostic value of fibroblast growth factor 23 in acute kidney injury: systematic review and meta-analysis#780680
- Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)#1353012
- Machine learning early risk assessment model for acute kidney injury in critically ill children: a retrospective cohort study.#399690
Record · ID 1184668
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive